Eris Lifesciences Limited (BOM:540596)

Market Cap	200.73B
Revenue (ttm)	27.24B
Net Income (ttm)	3.29B
Shares Out	n/a
EPS (ttm)	24.18
PE Ratio	60.95
Forward PE	n/a
Dividend	7.35 (0.53%)
Ex-Dividend Date	Feb 13, 2025

Volume	10,846
Average Volume	4,595
Open	1,499.80
Previous Close	1,471.45
Day's Range	1,427.20 - 1,521.70
52-Week Range	815.50 - 1,593.00
Beta	n/a
RSI	69.88
Earnings Date	May 23, 2025

About Eris Lifesciences

Eris Lifesciences Limited, together with its subsidiaries, provides domestic branded formulations for chronic and sub-chronic therapies in India. The company offers various branded formulations in various therapeutic areas, such as anti–diabetes, cardiovascular, nutrition, dermatology, neuroscience, gynecology, nephrology, and oncology, as well as central nervous system, women’s health, and vitamins/minerals/nutrients. It also provides patient care services, including ambulatory blood pressure measurement, ambulatory electrocardiogram measureme...

• Industry: Pharmaceutical Preparations
• Founded: 2007
• Employees: 3,620
• Stock Exchange: Bombay Stock Exchange
• Ticker Symbol: 540596

Financial Performance

In 2023, Eris Lifesciences's revenue was 19.91 billion, an increase of 19.83% compared to the previous year's 16.62 billion. Earnings were 3.92 billion, an increase of 2.57%.